Canada Post Corporation Pension Plan’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8M Buy
218,724
+40,975
+23% +$3.43M 0.69% 32
2026
Q1
$14.2M Buy
177,749
+14,751
+9% +$1.22M 0.57% 36
2025
Q4
$13.9M Buy
162,998
+3,120
+2% +$256K 0.53% 37
2025
Q3
$12.3M Buy
159,878
+1,630
+1% +$127K 0.55% 41
2025
Q2
$12.4M Buy
+158,248
New +$11.8M 0.73% 24
2025
Q1
Sell
-159,098
Closed -$11.8M 159
2024
Q4
$11.8M Buy
+159,098
New +$11.1M 0.7% 30

Other funds holding EW

Canada Post Corporation Pension Plan's EW Position: Q2 2026 in Review

Canada Post Corporation Pension Plan increased its Edwards Lifesciences (EW) stake by 23% in Q2 2026, buying an estimated $3.43M and bringing the position to 218,724 shares worth $19.8M. The position accounts for 0.69% of the portfolio, ranked #32.

Canada Post Corporation Pension Plan first reported a position in EW in Q4 2024 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Canada Post Corporation Pension Plan held 218,724 shares of Edwards Lifesciences worth $19.8M as of Q2 2026.
  • Canada Post Corporation Pension Plan bought 40,975 Edwards Lifesciences shares in Q2 2026, an estimated $3.43M.
  • Edwards Lifesciences made up 0.69% of Canada Post Corporation Pension Plan's portfolio in Q2 2026, its #32 holding.
  • Canada Post Corporation Pension Plan first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Canada Post Corporation Pension Plan's 13F filing for Q2 2026, filed 15 Jul 2026.